Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
Max M. Wattenberg(National Institutes of Health), James W. Hodge(Center for Cancer Research)
Cited by 27
Related Papers
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
|Oncotarget|2013|397
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
|Journal of Translational Medicine|2014|189
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
|Journal for ImmunoTherapy of Cancer|2020|148
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
|Oncotarget|2016|104
Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
|Cancer Immunology Research|2014|80